rs219873

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4_ModerateBA1

The NM_000834.5(GRIN2B):​c.-19+56416C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.755 in 152,050 control chromosomes in the GnomAD database, including 44,237 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.75 ( 44237 hom., cov: 31)

Consequence

GRIN2B
NM_000834.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.945

Publications

2 publications found
Variant links:
Genes affected
GRIN2B (HGNC:4586): (glutamate ionotropic receptor NMDA type subunit 2B) This gene encodes a member of the N-methyl-D-aspartate (NMDA) receptor family within the ionotropic glutamate receptor superfamily. The encoded protein is a subunit of the NMDA receptor ion channel which acts as an agonist binding site for glutamate. The NMDA receptors mediate a slow calcium-permeable component of excitatory synaptic transmission in the central nervous system. The NMDA receptors are heterotetramers of seven genetically encoded, differentially expressed subunits including NR1 (GRIN1), NR2 (GRIN2A, GRIN2B, GRIN2C, or GRIN2D) and NR3 (GRIN3A or GRIN3B). The early expression of this gene in development suggests a role in brain development, circuit formation, synaptic plasticity, and cellular migration and differentiation. Naturally occurring mutations within this gene are associated with neurodevelopmental disorders including autism spectrum disorder, attention deficit hyperactivity disorder, epilepsy, and schizophrenia. [provided by RefSeq, Aug 2017]
GRIN2B Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen, Ambry Genetics
  • developmental and epileptic encephalopathy, 27
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • intellectual disability, autosomal dominant 6
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • autosomal dominant non-syndromic intellectual disability
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • infantile spasms
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.37).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.849 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000834.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GRIN2B
NM_000834.5
MANE Select
c.-19+56416C>T
intron
N/ANP_000825.2Q13224
GRIN2B
NM_001413992.1
c.-19+56416C>T
intron
N/ANP_001400921.1A0A8D9PHB2
GRIN2B
NM_001413993.1
c.-18-57286C>T
intron
N/ANP_001400922.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GRIN2B
ENST00000609686.4
TSL:1 MANE Select
c.-19+56416C>T
intron
N/AENSP00000477455.1Q13224
GRIN2B
ENST00000630791.3
TSL:5
c.-19+56416C>T
intron
N/AENSP00000486677.3A0A0D9SFK0
GRIN2B
ENST00000627535.2
TSL:5
c.-19+56416C>T
intron
N/AENSP00000486411.1A0A0D9SFA0

Frequencies

GnomAD3 genomes
AF:
0.755
AC:
114697
AN:
151930
Hom.:
44212
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.637
Gnomad AMI
AF:
0.913
Gnomad AMR
AF:
0.648
Gnomad ASJ
AF:
0.788
Gnomad EAS
AF:
0.572
Gnomad SAS
AF:
0.780
Gnomad FIN
AF:
0.783
Gnomad MID
AF:
0.759
Gnomad NFE
AF:
0.855
Gnomad OTH
AF:
0.752
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.755
AC:
114781
AN:
152050
Hom.:
44237
Cov.:
31
AF XY:
0.750
AC XY:
55709
AN XY:
74322
show subpopulations
African (AFR)
AF:
0.637
AC:
26385
AN:
41426
American (AMR)
AF:
0.648
AC:
9904
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.788
AC:
2732
AN:
3468
East Asian (EAS)
AF:
0.573
AC:
2959
AN:
5168
South Asian (SAS)
AF:
0.781
AC:
3755
AN:
4810
European-Finnish (FIN)
AF:
0.783
AC:
8283
AN:
10578
Middle Eastern (MID)
AF:
0.762
AC:
224
AN:
294
European-Non Finnish (NFE)
AF:
0.855
AC:
58121
AN:
68006
Other (OTH)
AF:
0.751
AC:
1587
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1346
2692
4039
5385
6731
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
848
1696
2544
3392
4240
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.802
Hom.:
6155
Bravo
AF:
0.735
Asia WGS
AF:
0.680
AC:
2367
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.37
CADD
Benign
17
DANN
Benign
0.72
PhyloP100
0.94
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs219873; hg19: chr12-14076446; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.